Ocean View, DE -- (SBWIRE) -- 05/13/2020 -- Mammography systems market is expected to exceed USD 3.6 billion by 2025. Rising awareness about early detection of breast cancer coupled with availability of free breast screening programs will accelerate mammography systems market growth.

Some major findings of the mammography systems market report include:
- Presence of reimbursement policies for mammography screening procedures will drive the adoption of mammography in developed nations
- Innovations including personalized mammography by Hologic to enhance patient comfort while screening, will aid in driving customer preference
- Growing demand for 3D breast tomosynthesis will significantly contribute to mammography systems industry progress
- Major players operating in the mammography systems industry include Hologic, Inc., GE Healthcare, Siemens Healthineers, Fujifilm and Korean C among other players
- Competitors are undertaking inorganic growth strategies such as mergers, acquisitions and launch of new products to capitalize on market expansion opportunities and to gain competitive edge over others

Request sample copy of this report @ https://www.decresearch.com/request-sample/detail/2637

Increasing incidence of invasive breast cancer across the globe will stimulate mammography systems market growth in the upcoming years. The Breastcancer.org estimated that around one among eight women will develop invasive form of breast cancer during lifetime. Risk factors associated with breast cancer such as hormone replacement therapy, genetic factors, child-bearing and growing adoption of unhealthy lifestyle habits will further significantly contribute towards greater adoption of breast imaging modalities, thereby impacting mammography systems market growth over the projected years.

Technological advancements in mammography systems will offer lucrative opportunities for industry expansion in the foreseeable future. Breakthroughs in mammography such as use of synthesized 2D technology and digital breast tomosynthesis to reduce recall rate and offer effective detection of cancer in dense breast tissues will escalate the customer preference towards advanced mammography systems. Also, subsequent development of image processing solutions that aid in breast imaging will impact the industry size. For instance, in November 2018, Fujifilm announced launch of novel software and image processing enhancement for its ASPIRE Cristalle, at the RSNA 2018, aimed at augmenting clinical imaging. Aforementioned improvements aid in significantly lowering the mortality rate due to breast cancer, thus positively impacting the business growth over the coming years.

Make Inquiry about this report @ https://www.decresearch.com/inquiry-before-buying/2637

Analog mammography systems market accounted for substantial revenue of over USD 135 million in 2018. Analog mammography uses low dose of X-ray radiations and can detect changes into tissue up to 1-2mm in size. These machines are relatively cost-effective, and the generated images can be converted into digital form with computed radiography and saved as DICOM format. Therefore, adoption of affordable and technologically advanced systems, favorable for underdeveloped countries, will augment the segmental growth.

2D mammography systems segment accounted for around 70% revenue share in 2018. 2D technology systems offer improved outcomes and clearer images than screen film technology. Moreover, it reduces the exposure time and amount of radiation than screen film technology and provides high-quality image with better positioning. This technology is cost-effective than screen film technology due to reduced recall rates. Countries such as Canada, U.S., Japan, and others are rapidly adopting this technology for enhancing diagnosis rate of invasive cancer. Additionally, 2D technology is used in full-field mammography as well as breast tomosynthesis machines, thereby driving the segmental growth over the projected years.

Other end-users including clinics and diagnostic imaging centers will witness rapid progress during the analysis period. Adoption of mammography machines in diagnostic centers across emerging nations including India is increasing owing to tremendous expansion in the number of imaging centers. Additionally, growing initiatives for encouraging early screening of breast cancer coupled with improvements in healthcare infrastructure will further impact segmental growth over the forthcoming years.

UK mammography systems market is poised to witness 8.8% CAGR during the analysis period. Adoption of smoking and growing prevalence of obesity form the major risk factors for breast cancer. Moreover, UK has a centralized mammography screening program and focuses on proper mammogram reading in order to reduce false-positive results. According to the Cancer Research UK, every year, over 2 million women undergo breast screening. Thus, several risk factors coupled with availability of breast screening equipment will influence UK mammography systems industry growth.

Industry players are implementing numerous strategies such as product innovations and partnerships to gain competitive advantage for business expansion. In September 2018, Solis Mammography announced introduction of SmartCurve technology, that is co-developed with Hologic, to improve detection rate of invasive breast cancer and relieve patient discomfort during diagnosis. The product launch enabled company in expanding its product portfolio as well as existing customer base.